Meridian Bioscience (VIVO -1.4%) says it's successfully completed beta trials for two new...

|About: Meridian Bioscience Inc. (VIVO)|By:, SA News Editor

Meridian Bioscience (VIVO -1.4%) says it's successfully completed beta trials for two new illumigene molecular amplification tests. The assays are designed to specifically detect the DNA of Chlamydia trachomatis and Neisseria gonorrhoeae from both swab and urine samples.